Jordi Bruix
Impact in
- Hepatology top 0.01%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Hepatitis C virus research
- Liver physiology and pathology
- Epidemiology top 0.01%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Hepatology 298
- Hepatocellular Carcinoma Treatment and Prognosis 255
- Liver Disease and Transplantation 57
- Hepatitis C virus research 32
- Liver physiology and pathology 28
- Epidemiology 148
- Liver Disease Diagnosis and Treatment 129
- Hepatitis B Virus Studies 39
- Co-authors
- Josep M. Llovet (115 shared papers)Morris Sherman (16 shared papers)Alejandro Forner (75 shared papers)María Reig (93 shared papers)Concepció Brú (26 shared papers)Andrew K. Burroughs (2 shared papers)Carmen Ayuso (50 shared papers)Josep Fuster (31 shared papers)
- Journals
- Journal of Hepatology (84 papers)Hepatology (56 papers)Journal of Clinical Oncology (31 papers)Gastroenterology (15 papers)Annals of Oncology (13 papers)
- Partner nations
- SpainUnited StatesItaly
In The Last Decade
Jordi Bruix
382 papers receiving 76.5k citations
Jordi Bruix's Hit Papers
Peers
Comparison fields: 5 of 166
- Hepatology 52.1k
- Epidemiology 21.1k
- Cancer Research 8.6k
- Pathology and Forensic Medicine 5.5k
- Oncology 7.7k
Countries citing papers authored by Jordi Bruix
This map shows the geographic impact of Jordi Bruix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jordi Bruix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jordi Bruix more than expected).
Fields of papers citing papers by Jordi Bruix
This network shows the impact of papers produced by Jordi Bruix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jordi Bruix. The network helps show where Jordi Bruix may publish in the future.
Co-authors
The 25 scholars most cited alongside Jordi Bruix, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 395 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Management of Hepatocellular Carcinoma: An Update Δσ Hit paper breakdown → | 2011 | 6734 |
| 2 | Management of Hepatocellular Carcinoma * Hit paper breakdown → | 2005 | 4870 |
| 3 | Hepatocellular carcinoma Hit paper breakdown → | 2018 | 4228 |
| 4 | Hepatocellular carcinoma Hit paper breakdown → | 2012 | 3520 |
| 5 | Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference Hit paper breakdown → | 2001 | 3504 |
| 6 | Hepatocellular carcinoma Hit paper breakdown → | 2003 | 3214 |
| 7 | Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification Hit paper breakdown → | 1999 | 3063 |
| 8 | Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial Hit paper breakdown → | 2002 | 2802 |
| 9 | BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update Hit paper breakdown → | 2021 | 2546 |
| 10 | Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival Hit paper breakdown → | 2003 | 2443 |
| 11 | Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation Hit paper breakdown → | 1999 | 1370 |
| 12 | Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma Hit paper breakdown → | 2008 | 1334 |
| 13 | Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma Hit paper breakdown → | 2016 | 1291 |
| 14 | EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma European Association for the Study of the Liver ⇑ , European Organisation for Research and Treatment of Cancer Hit paper breakdown → | 2012 | 1277 |
| 15 | Hepatocellular carcinoma: clinical frontiers and perspectives Hit paper breakdown → | 2014 | 1109 |
| 16 | Natural History of Untreated Nonsurgical Hepatocellular Carcinoma: Rationale for the Design and Evaluation of Therapeutic Trials Hit paper breakdown → | 1999 | 1007 |
| 17 | Prognostic prediction and treatment strategy in hepatocellular carcinoma Hit paper breakdown → | 2002 | 935 |
| 18 | Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects Hit paper breakdown → | 2010 | 903 |
| 19 | Molecular targeted therapies in hepatocellular carcinoma† Hit paper breakdown → | 2008 | 850 |
| 20 | Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2015 | 809 |
About Jordi Bruix
Jordi Bruix is a scholar working on Hepatology, Epidemiology, Oncology, Cancer Research and Surgery, having authored 395 papers that have together received 78.4k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (255 papers), Liver Disease Diagnosis and Treatment (129 papers), Liver Disease and Transplantation (57 papers), Hepatitis B Virus Studies (39 papers), Hepatitis C virus research (32 papers), Cancer, Lipids, and Metabolism (32 papers), Liver physiology and pathology (28 papers) and Colorectal Cancer Treatments and Studies (28 papers). The work is most often cited by research in Hepatology (52.1k citations), Epidemiology (21.1k citations), Cancer Research (8.6k citations), Pathology and Forensic Medicine (5.5k citations) and Oncology (7.7k citations). Jordi Bruix has collaborated with scholars based in Spain, United States and Italy. Frequent co-authors include Josep M. Llovet, Morris Sherman, Alejandro Forner, María Reig, Concepció Brú, Andrew K. Burroughs, Carmen Ayuso, Josep Fuster, Vincenzo Mazzaferro and Joan Rodés. Their work appears in journals such as Journal of Hepatology, Hepatology, Journal of Clinical Oncology, Gastroenterology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.